Paladin Labs Inc.
- FDA Approves Impavido to Treat Tropical Disease Leishmaniasis - March 19, 2014
- Paladin Announces Extension of the Impavido PDUFA Date by Three Months - November 13, 2013
Drugs Associated with Paladin Labs Inc.
Paladin Labs Inc. manufactures, markets and/or distributes more than 2 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
Generic name: fomepizole
Drug class: antidotes
Generic name: miltefosine
Drug class: anthelmintics
|For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).|